vidarabine phosphate has been researched along with Bladder Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bochner, BH; Cordon-Cardo, C; Kasahara, N; Kikuchi, E; Logg, CR; Menendez, S; Ohori, M; Ozu, C | 1 |
1 other study(ies) available for vidarabine phosphate and Bladder Cancer
Article | Year |
---|---|
Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts.
Topics: Animals; Antimetabolites, Antineoplastic; Combined Modality Therapy; DNA Replication; Escherichia coli; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Leukemia Virus, Murine; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prodrugs; Purine-Nucleoside Phosphorylase; Transduction, Genetic; Transplantation, Heterologous; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vidarabine Phosphate | 2007 |